Compare Hims and Hers Health Inc (HIMS) vs TKO Group Holdings Inc (TKO) Price & Performance

Hims & Hers Health trades at $32.70, down 0.43% on the day, with a bearish technical signal despite bullish moving averages. The company reported $2.35 billion in 2025 revenue but swung to a projected net loss for 2026, with mixed quarterly earnings results. Recent news highlights executive changes and anticipation for Q2 2026 results on August 10, 2026, with analyst sentiment leaning toward a Buy consensus.

The outlook is cautious due to profitability concerns and high valuation multiples, but growth opportunities in weight-loss and telehealth services offer potential. Key risks include execution challenges and regulatory scrutiny. The stock presents a speculative growth play with a consensus price target of $33.57, slightly above the current price.

TKO trades at $182.79, down 1.26% today, with a bearish technical signal despite strong analyst support. The company shows solid revenue growth with 2026 projections at $5.1B and improved net profit margin of 4.47%. Recent developments include successful international events and an $800 million share repurchase, while earnings have been mixed with Q1 2026 beating expectations but Q3 and Q4 2025 missing.

Wall Street remains bullish with 89% buy ratings and a $228.40 consensus price target, representing 25% upside potential. Key risks include execution on earnings expectations and high valuation multiples. The stock presents a growth opportunity driven by live event demand and media partnerships, though investors should monitor quarterly performance against elevated expectations.